Page last updated: 2024-09-04

moxifloxacin and tedizolid phosphate

moxifloxacin has been researched along with tedizolid phosphate in 2 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(tedizolid phosphate)
Trials
(tedizolid phosphate)
Recent Studies (post-2010) (tedizolid phosphate)
3,1575521,69011524106

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, E; Flanagan, S; Litwin, J; Prokocimer, P1
Deshpande, D; Gumbo, T; Lee, PS; Pasipanodya, JG; Srivastava, S1

Trials

1 trial(s) available for moxifloxacin and tedizolid phosphate

ArticleYear
Effects of therapeutic and supratherapeutic doses of oral tedizolid phosphate on cardiac repolarisation in healthy volunteers: a randomised controlled study.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Humans; Male; Middle Aged; Moxifloxacin; Organophosphates; Oxazoles; Placebos; Young Adult

2016

Other Studies

1 other study(ies) available for moxifloxacin and tedizolid phosphate

ArticleYear
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    The Journal of antimicrobial chemotherapy, 2017, Sep-01, Volume: 72, Issue:suppl_2

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fluoroquinolones; Humans; Lung Diseases; Macrophages; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organophosphates; Oxazoles; Rifabutin; THP-1 Cells

2017